News & Events
Arcuro Medical Exceeds 4,000 Case Milestone
Meniscal Repair Innovator Continues U.S. Growth
5 August 2024
Arcuro Medical Ltd., today announced a key milestone of exceeding 4,000 surgical cases worldwide, and 1,000 cases in the U.S., with its SuperBall™ Meniscal Repair System.
The current version of the SuperBall Meniscal Repair System, commercially launched in 2022, with additional line extensions introduced in late 2023 addresses a full range of meniscus tear patterns.
Recently, Arcuro made two key hires in the United States to focus on commercial growth in this important market with orthopedic industry veterans Jamal Rushdy as CEO and Nick Tonno as Sales Director. The company’s focus is to continue to grow its business in the U.S. and expand its product offering.
Arcuro will provide a company update at the HealthpointCapital Investor Day on September 13, and exhibit at the Orthopaedic Summit: Evolving Techniques (OSET) meeting September 14 to 18, both in Las Vegas.
This news appeared in: OrthoSpineNews
We are excited to have reached this important milestone of global cases, and most significantly surpassing 1,000 cases here in the U.S. We look forward to continuing growth with our expanded U.S. sales organization.
Jamal Rushdy, CEO of Arcuro
The SuperBall Meniscal Repair System provides an important all-suture, knotless tool for surgeons to effectively address a wide range of tears. Its unique tensioning mechanism is similar to the inside-out gold standard technique and has been shown to provide superior strength and reduced deployment failure and other complications associated with other meniscus repair devices.
Philip Davidson, MD, Medical Director of Arcuro
See More News
FruitSpec raises $5 million
FruitSpec’s Yield Management Platform provides digital visibility of fruit yield data to entire supply-chain production units
Phytolon secures $4.1 million in funding
Funding for fermentation-based technology for the production of food colors
